SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : IMMD - ImmuDyne
IMMD 0.215-2.1%Jun 21 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark D. Smits Sr. who wrote (1065)6/16/1997 8:04:00 PM
From: semi-recumbent   of 1249
 
Carmel Research is one of the principles mentioned in the recent lawsuit which has been pending final settlement. Found this 6 month old blurb re the law suit as a reminder:

"What's New in Biotechnology?
December 6, 1996
Financial News

(REPEAT- 6 MONTHS OLD)

ImmuDyne Inc. has reached a settlement in principle for two lawsuits, which will include a net decrease of 1.7 million ImmuDyne shares outstanding, a $500,000 payment by the company to a plaintiff in one of the suits, and a decrease in royalty payments to Carmel Research Inc., a co-defendant, for licensing of patents and related technology will decrease to 10% from 12%."

Are these people the reason the final settlement of the law suit has been so hard to come by? The timing of this E-mail to Irene may indicate desperation on the part of someone anxious to keep the stock price from rising. Irene, thanks for sharing, even though I worry about the effect on stock price.

Sam
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext